Tech Company Financing Transactions

SphynKx Therapeutics Funding Round

SphynKx Therapeutics closed a financing round on 9/30/2013. Investors included CIT GAP Fund.

Transaction Overview

Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Charlottesville, VA 22902
USA
Phone
Undisclosed
Email Address
Overview
SphynKx Therapeutics LLC is a privately held biotechnology company based in Charlottesville, VA. At SphynKx, we strive to discover and develop novel therapies for the treatment of diseases such as cancer and fibrosis.
Profile
SphynKx Therapeutics LinkedIn Company Profile
Social Media
SphynKx Therapeutics Company Twitter Account
Company News
SphynKx Therapeutics News
Facebook
SphynKx Therapeutics on Facebook
YouTube
SphynKx Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Bolt
  Andrew Bolt LinkedIn Profile  Andrew Bolt Twitter Account  Andrew Bolt News  Andrew Bolt on Facebook
Chief Scientific Officer
Kevin Lynch
  Kevin Lynch LinkedIn Profile  Kevin Lynch Twitter Account  Kevin Lynch News  Kevin Lynch on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2013: Hulafrog venture capital transaction
Next: 9/30/2013: Profectus BioSciences venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary